| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/17/2003 | US20030134318 Methods of using randomized libraries of zinc finger proteins for the identification of gene function |
| 07/17/2003 | US20030134315 Testing a sample from a cancer patient for the expression of a negative signal transduction factor (NSTF) and for the expression of a positive signal transduction factor (PSTF), selecting chemotherapeutic agent for treatment based on above |
| 07/17/2003 | US20030134314 Assaying the ability of specific polypeptide activity, thereby identifying a compound capable of treating a hematologic disorder |
| 07/17/2003 | US20030134313 Polynucleotide containing nucleotide sequences encoding an aveC gene product, which polynucleotide molecule can be used to alter the ratio or amount of class 2:1 avermectins produced in fermentation culture of Streptomyces avemitilis |
| 07/17/2003 | US20030134312 Utilizes at least one primer for analysis; automatic for massed screening and the discovery of sequence variants of known virons, undetected virons and others |
| 07/17/2003 | US20030134309 Detection of hypermutable nucleic acid sequence in tissue |
| 07/17/2003 | US20030134308 Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma |
| 07/17/2003 | US20030134306 Human and murine cytokine polypeptides |
| 07/17/2003 | US20030134301 Nucleic acids, their expression products and pathways involved in pain, and their use in screening for molecule that can alleviate pain |
| 07/17/2003 | US20030134299 Surface saturation surfaces; hybrid nucleic acid |
| 07/17/2003 | US20030134298 Anticancer agents; hybrids; amplification; polymerase chain reactions |
| 07/17/2003 | US20030134295 Cell differentiation; amplification; hybridization |
| 07/17/2003 | US20030134290 Method for identifying polymorphisms |
| 07/17/2003 | US20030134286 Multilayer support of polylactone or polyamide and cationic polymer |
| 07/17/2003 | US20030134284 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134282 Quantitative analysis of tissue gene expression; amplification; polymerase chain reaction |
| 07/17/2003 | US20030134281 Nanomachine compositions and methods of use |
| 07/17/2003 | US20030134275 Telomerase reverse transcriptase (TERT) genes |
| 07/17/2003 | US20030134272 Mutation analysis of the NF1 gene |
| 07/17/2003 | US20030134270 Rapid method of selecting cells for gene disruption by homologous recombination |
| 07/17/2003 | US20030134268 Fast and exhaustive method for selecting a prey polypeptide interacting with a bait polypeptide of interest: application to the construction of maps of interactors polypeptides |
| 07/17/2003 | US20030134265 Screening method for nucleic acids |
| 07/17/2003 | US20030134263 Controlling gene expression; transfection of cell |
| 07/17/2003 | US20030133971 Positively charged and neutral lipids facilitates cellular uptake; liposomes |
| 07/17/2003 | US20030133943 Protective recombinant Haemophilus influenzae high molecular weight proteins |
| 07/17/2003 | US20030133933 Novel integrin alpha subunit |
| 07/17/2003 | US20030133919 An immunogene therapy for treating diseases associated with excessive interleukin-18 induced immunoreaction; administering a transfected cells, preventing autoimmune and allergic disease |
| 07/17/2003 | US20030133917 Therapeutic treatment of human tumors, cancers and infected cells; a viral vector containing a DNA insert as antitumor agents, anticarcinogenic agents, viricides, fungicides, bactericides |
| 07/17/2003 | US20030133912 Receptor-targeted adenoviral vectors |
| 07/17/2003 | US20030133911 Pneumovirus ns proteins antagonising the interferon (ifn) response |
| 07/17/2003 | US20030133910 Inhibiting cell proliferation by administering a large dosage of wild-type ras proteins |
| 07/17/2003 | US20030133909 An isolated polynucleotide encodes a polypeptide which comprising amino acids able to glycosylation, vaccines as an antitumor agent for treating mammal |
| 07/17/2003 | US20030132162 Underdrain for filtration membrane |
| 07/17/2003 | US20030131532 Floral packaging material having great masters prints thereon |
| 07/17/2003 | CA2854024A1 Corn plants with improved quality grain traits |
| 07/17/2003 | CA2805007A1 Transgenic plants expressing civps or intein modified proteins and related method |
| 07/17/2003 | CA2795814A1 Proteases producing an altered immunogenic response and methods of making and using the same |
| 07/17/2003 | CA2767061A1 Specific binding agents of human angiopoietin-2 |
| 07/17/2003 | CA2514872A1 Purification and characterization of hla proteins |
| 07/17/2003 | CA2473379A1 Methods of detecting hcv genotype 1 (hcv-1) by using primers specific for the 5' non-coding region (ncr) of the hcv genome |
| 07/17/2003 | CA2473226A1 Diagnostics and vaccines for mycrobacterium paratuberculosis infections |
| 07/17/2003 | CA2472927A1 A novel splice variant of myd88 and uses thereof |
| 07/17/2003 | CA2472826A1 Antibodies directed to pdgfd and uses thereof |
| 07/17/2003 | CA2472647A1 Mammal prolactin variants |
| 07/17/2003 | CA2472328A1 Fusion proteins |
| 07/17/2003 | CA2472282A1 Gene products differentially expressed in cancerous breast cells and their methods of use |
| 07/17/2003 | CA2472206A1 Proteases producing an altered immunogenic response and methods of making and using the same |
| 07/17/2003 | CA2472118A1 Pak5-related compositions and methods |
| 07/17/2003 | CA2472111A1 Human mast cell-expressed membrane proteins |
| 07/17/2003 | CA2472049A1 Dominant negative proteins and methods thereof |
| 07/17/2003 | CA2472026A1 Method for detecting human papillomavirus mrna |
| 07/17/2003 | CA2471972A1 Proteases producing an altered immunological response and methods of making and using the same |
| 07/17/2003 | CA2471936A1 Methods for using anti-muc18 antibodies |
| 07/17/2003 | CA2471874A1 Compositions and methods for hydroxylating epothilones |
| 07/17/2003 | CA2471868A1 Methods of generating multispecific, multivalent agents from vh and vl domains |
| 07/17/2003 | CA2471859A1 Thermotolerant phytase for animal feed |
| 07/17/2003 | CA2471840A1 Novel compositions and methods for cancer |
| 07/17/2003 | CA2471827A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
| 07/17/2003 | CA2471737A1 Expression of protective antigens in transgenic chloroplasts and the production of improved vaccines |
| 07/17/2003 | CA2471551A1 Methods to engineer mammalian-type carbohydrate structures |
| 07/17/2003 | CA2471504A1 Ligand for g-protein coupled receptor gpr43 and uses thereof |
| 07/17/2003 | CA2471432A1 Nonhuman model animal lacking the ability to control lymphocyte migration |
| 07/17/2003 | CA2471431A1 Compositions and methods for the diagnosis and treatment of tumor |
| 07/17/2003 | CA2471178A1 Recombinant protein expression |
| 07/17/2003 | CA2470528A1 Modular systems and methods for using sample processing devices |
| 07/17/2003 | CA2470277A1 Inducible transposition in transgenic organism using transposon vector |
| 07/17/2003 | CA2470012A1 Novel proteins and nucleic acids encoding same |
| 07/17/2003 | CA2469480A1 Use of biomolecular targets in the treatment and visualization of tumors |
| 07/17/2003 | CA2468888A1 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
| 07/17/2003 | CA2467084A1 Mutant chromophores/fluorophores and methods for making and using the same |
| 07/17/2003 | CA2467083A1 Viral capsid assembly intermediates |
| 07/17/2003 | CA2463798A1 Modulation of immunostimulatory propertiies of oligonucleotide-based compounds by optimal presentation of 5' ends |
| 07/17/2003 | CA2450814A1 Microarrays for cell phenotyping and manipulation |
| 07/16/2003 | EP1327691A2 Detection of respiratory viruses |
| 07/16/2003 | EP1327688A1 Adenoviruses with enhanced lytic potency |
| 07/16/2003 | EP1327687A1 Methods of infection with hepatitis c virus |
| 07/16/2003 | EP1327686A1 Farnesyl pyrophosphate synthase protein, nucleic acid and promoter region thereof |
| 07/16/2003 | EP1327685A1 Bzip transcripiton factors that controls expression of the storage protein in the rice plant |
| 07/16/2003 | EP1327684A1 DNAH5 and its use in diagnosis |
| 07/16/2003 | EP1327683A2 Human papilloma virus inhibition by a hairpin ribozyme |
| 07/16/2003 | EP1327682A1 Method for producing DNA |
| 07/16/2003 | EP1327679A1 Method of synthesizing polynucleotide |
| 07/16/2003 | EP1327638A1 Novel dendritic cell wall membrane and use thereof |
| 07/16/2003 | EP1327146A2 Compounds with a branched linker |
| 07/16/2003 | EP1327005A2 Method for selecting nucleic acids that bond with high-affinity to a target |
| 07/16/2003 | EP1327003A2 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products |
| 07/16/2003 | EP1327002A2 Antisense modulation of syntaxin 4 interacting protein expression |
| 07/16/2003 | EP1327000A2 Transposon mediated multiplex sequencing |
| 07/16/2003 | EP1326998A2 Cd38 modulated chemotaxis |
| 07/16/2003 | EP1326997A2 Model for neurodegenerative diseases involving amyloid accumulation |
| 07/16/2003 | EP1326995A2 Method for synthesising peptides, peptide mimetics and proteins |
| 07/16/2003 | EP1326994A2 Improved method for the biosynthesis of vitamin e |
| 07/16/2003 | EP1326993A2 PRODUCTION OF g(a)-HYDROXY-CARBOXYLIC ACIDS USING A COUPLED ENZYME SYSTEM |
| 07/16/2003 | EP1326992A1 Method for circularizing adenoviral nucleic acid via homologous recombination |
| 07/16/2003 | EP1326991A2 Expression vectors and uses thereof |
| 07/16/2003 | EP1326990A2 Packaging of positive-strand rna virus replicon particles |
| 07/16/2003 | EP1326989A1 EXPRESSION VECTORS WITH MODIFIED ColE1 ORIGIN OF REPLICATION FOR CONTROL OF PLASMID COPY NUMBER |
| 07/16/2003 | EP1326988A1 High efficiency retroviral vector which contains genetically engineered cellular non-coding sequence harboring splicing acceptor |
| 07/16/2003 | EP1326987A1 Chimeric cytoplasmic signalling molecules derived from cd137 |
| 07/16/2003 | EP1326986A2 Regulation of human sphingosine kinase-like protein |